Systemic amyloidosis from A (AA) to T (ATTR): a reviewEli Muchtar, Morie A. Gertz, Angela Dispenzieri et al.|Journal of Internal Medicine|2020Cited by 329
Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatmentHila Magen, Eli Muchtar|Therapeutic Advances in Hematology|2016Cited by 68
A practical review on carfilzomib in multiple myelomaEli Muchtar, Hila Magen, Morie A. Gertz|European Journal Of Haematology|2016Cited by 68
Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational studyEli Muchtar, Hila Magen, Celia Suriu et al.|British Journal of Haematology|2015Cited by 38